Cargando…

Targeting Tissue Factor to Tumor Vasculature to Induce Tumor Infarction

SIMPLE SUMMARY: Among multiple other functional roles of tissue factor (TF) and other coagulation proteins in the development and targeting of malignant disease, some scientific groups are attempting to modify TF and target the molecule or truncated forms of the molecule to tumor vasculature to sele...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berdel, Andrew F., Schwöppe, Christian, Brand, Caroline, Harrach, Saliha, Brömmel, Kathrin, Hintelmann, Heike, Lenz, Georg, Liersch, Ruediger, Heinzow, Hauke, Schliemann, Christoph, Mesters, Rolf M., Berdel, Wolfgang E., Kessler, Torsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201357/ https://www.ncbi.nlm.nih.gov/pubmed/34200318 http://dx.doi.org/10.3390/cancers13112841

Ejemplares similares

Animal Safety, Toxicology, and Pharmacokinetic Studies According to the ICH S9 Guideline for a Novel Fusion Protein tTF-NGR Targeting Procoagulatory Activity into Tumor Vasculature: Are Results Predictive for Humans?
por: Berdel, Wolfgang E., et al.
Publicado: (2020)

Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcoma
por: Brand, Caroline, et al.
Publicado: (2020)

Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarction
por: Stucke-Ring, Janine, et al.
Publicado: (2016)

NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor
por: Brand, Caroline, et al.
Publicado: (2016)

Analysis of a novel highly metastatic melanoma cell line identifies osteopontin as a new lymphangiogenic factor
por: LIERSCH, RUEDIGER, et al.
Publicado: (2012)

Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue Sarcoma
por: Kessler, Torsten, et al.
Publicado: (2018)

First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study
por: Schliemann, Christoph, et al.
Publicado: (2020)

Multiparametric Magnetic Resonance Imaging for Immediate Target Hit Assessment of CD13—Targeted Tissue Factor tTF-NGR in Advanced Malignant Disease
por: Gerwing, Mirjam, et al.
Publicado: (2021)

Induced lymphatic sinus hyperplasia in sentinel lymph nodes by VEGF-C as the earliest premetastatic indicator
por: LIERSCH, RUEDIGER, et al.
Publicado: (2012)

Potential therapeutic impact of CD13 expression in non-small cell lung cancer
por: Schmidt, Lars Henning, et al.
Publicado: (2017)

Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancer
por: Schmidt, Lars Henning, et al.
Publicado: (2017)

CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering process
por: Altvater, Bianca, et al.
Publicado: (2023)

Amsacrine-based induction therapy in AML patients with cardiac comorbidities: a retrospective single-center analysis
por: Kuron, David, et al.
Publicado: (2023)

Gadofosveset-enhanced MRI as simple surrogate parameter for real-time evaluation of the initial tumour vessel infarction by retargeted tissue factor tTF-NGR
por: Höink, Anna, et al.
Publicado: (2019)

The role of autologous stem cell transplantation (ASCT) in aggressive B-cell lymphomas: real-world data from a retrospective single-center analysis
por: Wullenkord, Ramona, et al.
Publicado: (2021)

Long-term survival and polyclonal immunoglobulin reconstitution after allogeneic stem cell transplantation in multiple myeloma
por: Eisfeld, Christine, et al.
Publicado: (2020)

Adjuvant chemotherapy—Radiotherapy—Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 cases
por: Schliemann, Christoph, et al.
Publicado: (2018)

Characteristics and Outcome of Elderly Patients (>55 Years) with Acute Lymphoblastic Leukemia
por: Wenge, Daniela V., et al.
Publicado: (2022)

Magnesium levels and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
por: Angenendt, Linus, et al.
Publicado: (2020)

Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse
por: Berdel, Andrew F., et al.
Publicado: (2022)

Perioperative Chemotherapy in Gastroesophageal Cancer. A Retrospective Monocenter Evaluation of 42 Cases
por: Brehler, Ann-Christin E., et al.
Publicado: (2015)

Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia
por: Lutz, Mathias, et al.
Publicado: (2017)

Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer
por: Schulze, Arik Bernard, et al.
Publicado: (2019)

Upstream open reading frames regulate translation of cancer-associated transcripts and encode HLA-presented immunogenic tumor antigens
por: Nelde, Annika, et al.
Publicado: (2022)

Neuropilins in the Context of Tumor Vasculature
por: Niland, Stephan, et al.
Publicado: (2019)

L1 in tumor vasculature
por: Cavallaro, Ugo
Publicado: (2016)

A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy
por: Berdel, Andrew F., et al.
Publicado: (2022)

Normalization of tumor vasculature by R-Ras
por: Sawada, Junko, et al.
Publicado: (2012)

Nucleic Acid Sensing in the Tumor Vasculature
por: Baris, Adrian M., et al.
Publicado: (2021)

Tumor‐Cell‐Specific Targeting of Ibrutinib: Introducing Electrostatic Antibody‐Inhibitor Conjugates (AiCs)
por: Faust, Andreas, et al.
Publicado: (2021)

Calcitonin receptor‐like (CALCRL) is a marker of stemness and an independent predictor of outcome in pediatric AML
por: Angenendt, Linus, et al.
Publicado: (2021)

Integrated RNAi screening identifies the NEDDylation pathway as a synergistic partner of azacytidine in acute myeloid leukemia
por: Klosner, Justine, et al.
Publicado: (2021)

The tumor vasculature an attractive CAR T cell target in solid tumors
por: Akbari, Parvin, et al.
Publicado: (2019)

Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis
por: MOHR, MICHAEL, et al.
Publicado: (2014)

Thioaptamer Conjugated Liposomes for Tumor Vasculature Targeting
por: Mann, Aman P., et al.
Publicado: (2010)

Control of the Adaptive Immune Response by Tumor Vasculature
por: Mauge, Laetitia, et al.
Publicado: (2014)

Targeting the tumor vasculature to enhance T cell activity
por: Lanitis, Evripidis, et al.
Publicado: (2015)

Design Optimization of Tumor Vasculature-Bound Nanoparticles
por: Chamseddine, Ibrahim M., et al.
Publicado: (2018)

Normalization of Tumor Vasculature by Oxygen Microbubbles with Ultrasound
por: Ho, Yi-Ju, et al.
Publicado: (2019)

Immunotherapies targeting tumor vasculature: challenges and opportunities
por: Dianat-Moghadam, Hassan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pcu5p6fnkgc8grfhg082ke060v